RATIONALE: Although innate immunity is increasingly recognized to contribute to lung allograft rejection, the significance of endogenous innate ligands, such as hyaluronan (HA) fragments, in clinical or experimental lung transplantation is uncertain. OBJECTIVES: To determine if HA is associated with clinical bronchiolitis obliterans syndrome (BOS) in lung transplant recipients, and evaluate the effect of low- or high-molecular-weight HA on experimental lung allograft rejection, including dependence on innate signaling pathways or effector cells. METHODS: HA concentrations were measured in bronchoalveolar lavage and plasma samples from lung recipients with or without established BOS. BOS and normal lung tissues were assessed for HA localization and expression of HA synthases. Murine orthotopic lung recipients with established tolerance were treated with low- or high-molecular-weight HA under varied experimental conditions, including Toll-like receptor (TLR) 2/4 and myeloid differentiation protein 88 deficiency and neutrophil depletion. MEASUREMENTS AND MAIN RESULTS: HA localized within areas of intraluminal small airways fibrosis in BOS lung tissue. Moreover, transcripts for HA synthase enzymes were significantly elevated in BOS versus normal lung tissues and both lavage fluid and plasma HA concentrations were increased in recipients with BOS. Treatment with low-molecular-weight HA abrogated tolerance in murine orthotopic lung recipients in a TLR2/4- and myeloid differentiation protein 88-dependent fashion and drove expansion of alloantigen-specific T lymphocytes. Additionally, TLR-dependent signals stimulated neutrophilia that promoted rejection. In contrast, high-molecular-weight HA attenuated basal allograft inflammation. CONCLUSIONS: These data suggest that accumulation of HA could contribute to BOS by directly activating innate immune signaling pathways that promote allograft rejection and neutrophilia.
RATIONALE: Although innate immunity is increasingly recognized to contribute to lung allograft rejection, the significance of endogenous innate ligands, such as hyaluronan (HA) fragments, in clinical or experimental lung transplantation is uncertain. OBJECTIVES: To determine if HA is associated with clinical bronchiolitis obliterans syndrome (BOS) in lung transplant recipients, and evaluate the effect of low- or high-molecular-weight HA on experimental lung allograft rejection, including dependence on innate signaling pathways or effector cells. METHODS:HA concentrations were measured in bronchoalveolar lavage and plasma samples from lung recipients with or without established BOS. BOS and normal lung tissues were assessed for HA localization and expression of HA synthases. Murine orthotopic lung recipients with established tolerance were treated with low- or high-molecular-weight HA under varied experimental conditions, including Toll-like receptor (TLR) 2/4 and myeloid differentiation protein 88 deficiency and neutrophil depletion. MEASUREMENTS AND MAIN RESULTS:HA localized within areas of intraluminal small airways fibrosis in BOS lung tissue. Moreover, transcripts for HA synthase enzymes were significantly elevated in BOS versus normal lung tissues and both lavage fluid and plasma HA concentrations were increased in recipients with BOS. Treatment with low-molecular-weight HA abrogated tolerance in murine orthotopic lung recipients in a TLR2/4- and myeloid differentiation protein 88-dependent fashion and drove expansion of alloantigen-specific T lymphocytes. Additionally, TLR-dependent signals stimulated neutrophilia that promoted rejection. In contrast, high-molecular-weight HA attenuated basal allograft inflammation. CONCLUSIONS: These data suggest that accumulation of HA could contribute to BOS by directly activating innate immune signaling pathways that promote allograft rejection and neutrophilia.
Authors: Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem Journal: J Heart Lung Transplant Date: 2002-03 Impact factor: 10.247
Authors: S A Yousem; G J Berry; P T Cagle; D Chamberlain; A N Husain; R H Hruban; A Marchevsky; N P Ohori; J Ritter; S Stewart; H D Tazelaar Journal: J Heart Lung Transplant Date: 1996-01 Impact factor: 10.247
Authors: Dianhua Jiang; Jiurong Liang; Juan Fan; Shuang Yu; Suping Chen; Yi Luo; Glenn D Prestwich; Marcella M Mascarenhas; Hari G Garg; Deborah A Quinn; Robert J Homer; Daniel R Goldstein; Richard Bucala; Patty J Lee; Ruslan Medzhitov; Paul W Noble Journal: Nat Med Date: 2005-10-23 Impact factor: 53.440
Authors: Scott M Palmer; Lauranell H Burch; Anil J Trindade; R Duane Davis; Walter F Herczyk; Nancy L Reinsmoen; David A Schwartz Journal: Am J Respir Crit Care Med Date: 2005-01-07 Impact factor: 21.405
Authors: Marcella M Mascarenhas; Regina M Day; Cristiaan D Ochoa; Won-Il Choi; Lunyin Yu; Bin Ouyang; Hari G Garg; Charles A Hales; Deborah A Quinn Journal: Am J Respir Cell Mol Biol Date: 2003-05-08 Impact factor: 6.914
Authors: X Jiang; T T Nguyen; W Tian; Y K Sung; K Yuan; J Qian; J Rajadas; J-M Sallenave; N P Nickel; V de Jesus Perez; M Rabinovitch; M R Nicolls Journal: Am J Transplant Date: 2015-02-27 Impact factor: 8.086
Authors: Benjamin Stump; Ye Cui; Pranav Kidambi; Anthony M Lamattina; Souheil El-Chemaly Journal: Am J Respir Cell Mol Biol Date: 2017-09 Impact factor: 6.914
Authors: Ye Cui; Kaifeng Liu; Maria E Monzon-Medina; Robert F Padera; Hao Wang; Gautam George; Demet Toprak; Elie Abdelnour; Emmanuel D'Agostino; Hilary J Goldberg; Mark A Perrella; Rosanna Malbran Forteza; Ivan O Rosas; Gary Visner; Souheil El-Chemaly Journal: J Clin Invest Date: 2015-10-20 Impact factor: 14.808
Authors: Wenjun Li; Jason M Gauthier; Alice Y Tong; Yuriko Terada; Ryuji Higashikubo; Christian C Frye; Margaret S Harrison; Kohei Hashimoto; Amit I Bery; Jon H Ritter; Ruben G Nava; Varun Puri; Brian W Wong; Kory J Lavine; Ankit Bharat; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel Journal: J Clin Invest Date: 2020-12-01 Impact factor: 14.808
Authors: Ahmed Lazrak; Judy Creighton; Zhihong Yu; Svetlana Komarova; Stephen F Doran; Saurabh Aggarwal; Charles W Emala; Vandy P Stober; Carol S Trempus; Stavros Garantziotis; Sadis Matalon Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-03-06 Impact factor: 5.464
Authors: Davide Scozzi; Mohsen Ibrahim; Cecilia Menna; Alexander S Krupnick; Daniel Kreisel; Andrew E Gelman Journal: Am J Transplant Date: 2016-07-25 Impact factor: 8.086